Skip Navigation

DNA Research 2000 7(3):207-212; doi:10.1093/dnares/7.3.207
© 2000 by Kazusa DNA Research Institute
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (4)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Togashi, T.
Right arrow Articles by Sakaki, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Togashi, T.
Right arrow Articles by Sakaki, Y.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


A Novel Gene, DSCR5, from the Distal Down Syndrome Critical Region on Chromosome 21q22.2

Takushi Togashi1, Dong-Kug Choi2,3, Todd D. Taylor2, Yutaka Suzuki1,2, Sumio Sugano1, Masahira Hattori2,3 and Yoshiyuki Sakaki2,3,*

1Department of Virology, The Institute of Medical Science, University of Tokyo 4-6-1, Shirokanedai, Minato-ku, Tokyo 108-8639, Japan
2Genomic Sciences Center, Institute of Physical and Chemical Research (RIKEN-GSC) 2-1, Hirosawa, Wako-shi, Saitama 351-0106, Japan
3Human Genome Center, The Institute of Medical Science, University of Tokyo 4-6-1, Shirokanedai, Minato-ku, Tokyo 108-8639, Japan

* To whom correspondence should be addressed. Human Genome Center, The Institute of Medical Science, University of Tokyo, 4-6-1, Shirokanedai, Minato-ku, Tokyo 108-8639, Japan, Tel. +81-3-5449-5623, Fax. +81-3-5449-5445, E-mail: sakaki{at}ims.u-tokyo.ac.jp

Based on a detailed sequence of the distal Down syndrome critical region (DSCR), we predicted and molecularly cloned a novel gene, designated DSCR5. We determined the sequences of expressed sequence tags (ESTs) that almost matched the predicted cDNA sequence of DSCR5. Northern blot analysis showed that DSCR5 is expressed in several tissues including the liver, skeletal muscle, heart, pancreas and testis. To determine the 5'-end of DSCR5, the oligo-capping method was employed. Combining the EST sequence data and that from the oligo-capping experiments, we obtained the full-length cDNA sequence of DSCR5. DSCR5 had at least four types of alternatively spliced variants. According to the number of exons, they could be classified into two subtypes: DSCR5{alpha}1 and DSCR5ß. DSCR5{alpha} includes three splice variant subtypes, DSCR5{alpha}1, {alpha}2 and {alpha}3, which each has different first non-coding exon. In addition, the most abundantly isolated form, DSCR5{alpha}1, shows microheterogeneity of the mRNA start site. Comparison of the sequences between the predicted cDNA and the molecularly cloned cDNA revealed that the computer programs had limited validity to correctly predict the terminal exons. Thus, molecular cloning should always be required to complement the inadequacy of the computer predictions.

Key words: cDNA cloning; Down syndrome; oligo-capping


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
DevelopmentHome page
M. Shao, Z.-Z. Liu, C.-D. Wang, H.-Y. Li, C. Carron, H.-W. Zhang, and D.-L. Shi
Down syndrome critical region protein 5 regulates membrane localization of Wnt receptors, Dishevelled stability and convergent extension in vertebrate embryos
Development, June 15, 2009; 136(12): 2121 - 2131.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.